Floatz logo

Ticagrelor

Cardiac Disease

Assistance Publique - Hôpitaux de ParisSmall moleculePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

13 Active assets in the Cardiac Disease cohort.

Asset / SponsorPhaseRating
POTASSIUM
Tufts Medical Center
Phase 3BB
Orlistat
University of British Columbia
Phase 4BB
Acoramidis
Eidos Therapeutics, a BridgeBio company
Phase 3BB
Calcium
Phase 3BB
VITAMIN D
Phase 3BB

View all 36 →

Same molecule, other indications

Ticagrelor is also rated in:

myocardial infarctionDormant
BBB
Indicative ·
78 / 100
View asset →
ischemic strokeDormant
BBB
Indicative ·
76 / 100
View asset →
transient ischemic attackDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →